1.
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
by Di Cesare, Mariachiara
The Lancet (British edition), 2017-01-07, Vol.389 (10064), p.37-55
2.
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
by Heerspink, Hiddo J Lambers, PharmD
The Lancet (British edition), 2009, Vol.373 (9668), p.1009-1015
3.
Paricalcitol for reduction of albuminuria in diabetes Reply
by de Zeeuw, Dick
The Lancet (British edition), 2011-02-19, Vol.377 (9766), p.636-637
4.
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
by Matsushita, Kunihiro
The Lancet (British edition), 2010, Vol.375 (9731), p.2073-2081
5.
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
by de Zeeuw, Dick, Prof
The Lancet (British edition), 2010, Vol.376 (9752), p.1543-1551
6.
Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey
by Parkinson, I S
The Lancet (British edition), 1979-02-24, Vol.1 (8113), p.406
7.
A possible role for propranolol in the treatment of renal osteodystrophy
by Caro, J F
The Lancet (British edition), 1978-08-26, Vol.2 (8087), p.451-454
8.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Glob...
by Abd-Allah, Foad
The Lancet (British edition), 2017-09-16, Vol.390 (10100), p.1211-1259
9.
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016:...
by Abate, Kalkidan Hassen
The Lancet (British edition), 2017-09-16, Vol.390 (10100), p.1260-1344
10.
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Bu...
by Abbas, Kaja M
The Lancet (British edition), 2017, Vol.390 (10091), p.231-266
11.
Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia
by Wills, M R
The Lancet (British edition), 1983-07-02, Vol.2 (8340), p.29
12.
Long-term effects of small doses of 1,25-dihydroxycholecalciferol in renal osteodystrophy
by Ahmed, K Y
The Lancet (British edition), 1978-03-25, Vol.1 (8065), p.629-632
13.
Impairment of renal function in patients on 1alpha-hydroxycholecalciferol
by Winterborn, M H
The Lancet (British edition), 1978-07-15, Vol.2 (8081), p.150
14.
Propranolol in uraemic osteodystrophy
by Eastwood, J B
The Lancet (British edition), 1979-02-17, Vol.1 (8112), p.386-387
15.
Serum-25-hydroxycholecalciferol and renal osteodystrophy
by Nielsen, H E
The Lancet (British edition), 1977-04-02, Vol.1 (8014), p.754
16.
Impairment of renal function in patients on 1alpha-hydroxycholecalciferol
The Lancet (British edition), 1978-08-19, Vol.2 (8086), p.427
17.
Measurement of density and structure in bones
by Schönau, Eckhard
The Lancet (British edition), 1994, Vol.343 (8913), p.1635-1636
18.
Low-dose vitamin D analogues for renal osteodystrophy
The Lancet (British edition), 1989-06-17, Vol.1 (8651), p.1364-1365
19.
1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure
by Chalmers, T M
The Lancet (British edition), 1973-09-29, Vol.2 (7831), p.696-699
20.
1alpha-hydroxyvitamin D
by Brancaccio, D
The Lancet (British edition), 1978-06-17, Vol.1 (8077), p.1314-1315
Filter electronic articles 219 Hits
Remove Filters
- Journal Title
- The Lancet
- Lancet (8)
- Publikationer Från Örebro Univ... (3)